CONTRAVE

Serial Number 77926232
606

Registration Progress

Application Filed
Feb 2, 2010
Under Examination
Aug 10, 2010
Approved for Publication
Jun 15, 2010
Published for Opposition
Jun 15, 2010
Registered

Trademark Image

CONTRAVE

Basic Information

Serial Number
77926232
Filing Date
February 2, 2010
Published for Opposition
June 15, 2010
Abandonment Date
September 9, 2013
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Sep 9, 2013
Classes
005 016 044

Rights Holder

Orexigen Therapeutics, Inc.

03
Address
3344 North Torrey Pines Court, Suite 200
La Jolla, CA 92037

Ownership History

Orexigen Therapeutics, Inc.

Original Applicant
03
La Jolla, CA

Orexigen Therapeutics, Inc.

Owner at Publication
03
La Jolla, CA

Legal Representation

Attorney
AnneMarie Kaiser

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

33 events
Date Code Type Description
Sep 9, 2013 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
Sep 9, 2013 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 12, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 11, 2013 EX5G S SOU EXTENSION 5 GRANTED
Feb 5, 2013 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 5, 2013 EXT5 S SOU EXTENSION 5 FILED
May 15, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 14, 2012 EX4G S SOU EXTENSION 4 GRANTED
May 4, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
May 4, 2012 EXT4 S SOU EXTENSION 4 FILED
Mar 29, 2012 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 28, 2012 EX3G S SOU EXTENSION 3 GRANTED
Feb 7, 2012 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 7, 2012 EXT3 S SOU EXTENSION 3 FILED
Aug 19, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2011 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 18, 2011 EX2G S SOU EXTENSION 2 GRANTED
Aug 9, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 9, 2011 EXT2 S SOU EXTENSION 2 FILED
Feb 11, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 9, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 9, 2011 EXT1 S SOU EXTENSION 1 FILED
Feb 9, 2011 EX1G S SOU EXTENSION 1 GRANTED
Aug 10, 2010 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 15, 2010 PUBO A PUBLISHED FOR OPPOSITION
Jun 15, 2010 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2010 ALIE A ASSIGNED TO LIE
May 12, 2010 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
May 3, 2010 DOCK D ASSIGNED TO EXAMINER
May 3, 2010 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2010 MDSC O NOTICE OF DESIGN SEARCH CODE MAILED
Feb 11, 2010 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2010 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
pharmaceutical preparations for use in the treatment of obesity and inducing weight loss
First Use Anywhere: 0
First Use in Commerce: 0
Class 016
printed materials, namely, brochures, newsletters and bulletins on the topic of weight management and treatment of obesity
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
providing medical information in the field of weight management and the treatment of obesity
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of a series of bars of descending height above the word Contrave.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 016 044